title: Primary PCI in dabigatran-treated patient: is transradial approach and bivalirudin infusion a safe and effective therapeutic option?
authors.affiliation: Interventional Cardiology, Cath Lab Policlinico Casilino, Via Casilina, 1049, 00168, Rome, Italy, f.summaria@gmail.com.
authors.forename: Francesco
authors.initials: F
authors.lastname: Summaria
authors.forename: Enrico
authors.initials: E
authors.lastname: Romagnoli
authors.forename: Marina
authors.initials: M
authors.lastname: Mustilli
authors.forename: Roberto
authors.initials: R
authors.lastname: Patrizi
authors.forename: Adolfo
authors.initials: A
authors.lastname: Pagnanelli
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000008:administration & dosage*; D000069604:Dabigatran / Q000627:therapeutic use*; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage*; D062645:Percutaneous Coronary Intervention; D017534:Radial Artery; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D000069604:Dabigatran; C074619:bivalirudin